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Osteosarcoma (OS) is a rare malignant bone tumor. It affects mostly young persons and
has poor outcome with the present treatment. No improvement was observed since the
introduction of chemotherapy. The better understanding of osteosarcoma development
could indicate better management strategy. Repetitive DNA elements were found to
play a role in cancer mechanism especially in epithelial tumors but not yet analyzed in
osteosarcoma. We conducted the study to analyse the expression profile of repetitive
elements (RE) in osteosarcoma.
Methods: Fresh bone paired (tumor and normal bone) samples were obtained from
excised parts of tumors of 18 patients with osteosarcoma. We performed sequencing
of RNA extracted from 36 samples (18 tumor tissues and 18 normal bone for controls),
mapped raw reads to the human genome and identified the REs. EdgeR package was
used to analyse the difference in expression of REs between osteosarcoma and normal
bone.
Results: 82 REs were found differentially expressed (FDR < 0.05) between
osteosarcoma and normal bone. Out of all significantly changed REs, 35 were
upregulated and 47 were downregulated. HERVs (THE1C-int, LTR5, MER57F and
MER87B) and satellite elements (HSATII, ALR-alpha) were the most significantly
differential expressed elements between osteosarcoma and normal tissues. These results
suggest significant impact of REs in the osteosarcoma. The role of REs should be further
studied to understand the mechanism they have in the genesis of osteosarcoma.
Keywords: osteosarcoma, human endogenous retrovirus, sequence, satellite, repetitive elements, transposable
elements
IMPACT STATEMENT
Osteosarcoma is a very aggressive bone cancer. It is rare but it touches dominantly adolescence.
No changes in outcome of the present treatment for this poor prognosis disease makes additional
research necessary. We sequenced total RNA from 36 fresh-frozen paired samples (18 tumor and
18 non-tumor) from osteosarcoma patients.We found 82 repetitive DNA elements (REs) expressed
differently between osteosarcoma and normal bone. We believe that the results would contribute
to the understanding of OS and provide new approach for further studies in this area.
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INTRODUCTION
Osteosarcoma is a rare cancer which affects 0.2–0.35/100 000
across countries with a slightly higher frequency in male than
female (Mirabello et al., 2009a; Valery et al., 2015). It is the
most common malignant bone tumor (Mirabello et al., 2009b).
The highest peaked incidence was observed in women at 10–14
years and in men at age 15–19 years worldwide. There is a
lower second peak in elderly (Mirabello et al., 2009a; Hung et al.,
2014). The combination of surgery and chemotherapy remains
standard of care. Introduction of effective chemotherapy during
1960s−1980s increased the cure rate from <10% to 60–75% but
no more gain later on (Jaffe et al., 2013). Many studies were
carried out for understanding more about the mechanism of
osteosarcoma and to look for more new effective treatment.
The initial sequencing of the human genome in 2001
showed that repetitive DNA sequences accounted for at least
50% of the genome (Lander et al., 2001). But more recent
computational approaches stated a higher proportion as two-
thirds of repetitive elements in the human genome (de Koning
et al., 2011). They were classified into five classes: transposon-
derived repeats, simple sequence repeats; segmental duplications;
blocks of tandemly repeated sequences and ribosomal gene
clusters (Lander et al., 2001). They can also be classified into
two broad classes: tandem repeats and transposable elements
(Padeken et al., 2015). Tandem repeats included satellite DNA,
minisatellite and microsatellite (Padeken et al., 2015). While
transposable elements were classified into retrotransposon (class
I) and DNA transposons (class II). About 45% of genome belongs
to transposon-derived repeats. Class I retrotransposons includes
long terminal repeat (LTR)/human endogenous retroviruses
(HERVs) and non-LTR retrotransposons such as LINEs (Long
Interspersed Nuclear Elements) and SINEs (Short Interspersed
Nuclear Elements) (Lander et al., 2001; Rebollo et al., 2012).
Human endogenous retroviruses (HERVs) are a family of viruses
integrated in our genome which have similarities with the
nowadays exogenous retroviruses (Nelson et al., 2003). HERVs
account for about 8% of human DNA (Lander et al., 2001;
Cegolon et al., 2013). They are typically composed of gag, pol and
env regions sandwiched between the two LTRs (long terminal
repeats) (Nelson et al., 2003; Bannert and Kurth, 2004; Mager and
Stoye, 2015).
Repetitive elements are found to be associated to some
epithelial cancers. Overexpression of CT (centromeric) and PCT
(pericentric) sequences was found in cancer tissues compared
to normal tissues of the same patient who got testicular, liver,
ovarian, and lung cancers (Eymery et al., 2009). Digital gene
expression analysis of 15 pancreatic ductal carcinomas showed
a median 21-fold increased expression of total amount of all
satellite transcripts compared with normal pancreas. And the
pericentromeric human satellite II (HSATII) was the biggest
differentially expressed satellite subfamily which was not able
to be detected in normal human pancreas and was expressed
minimally in other normal tissues. Overexpression of HSATII
was also observed in other human cancers including lung (2
of 2), kidney (2 of 2), ovarian (2 of 2), and prostate (3 of 3)
(Ting et al., 2011; Bersani et al., 2015). The presence of a level
of GSATII, TAR1, and/or SST1 satellite transcripts below the
reference level indicates that subject has a tumor (Schiavetti
et al., 2002; Ting et al., 2012; Bersani et al., 2015). Alpha human
satellite DNA was overexpressed (43 times) in pancreatic cancer
compared to normal pancreas (Ting et al., 2011). Transcripts
from HERV-K HML-2 have been found to be associated with
many cancers such as melanoma (Schiavetti et al., 2002) leukemia
and lymphoma (Contreras-Galindo et al., 2008) as well as tumors
of the breast (Pichon et al., 2006; Wang-Johanning et al., 2007)
testis (Pichon et al., 2006) and ovary (Wang-Johanning et al.,
2007). The HERV-E family has been found to be correlated with
prostate, kidney, ovarian and uterine cancers (Wang-Johanning
et al., 2003; Gimenez et al., 2010). HERV-H sequences was found
to be overexpressed in colorectal carcinogenesis (Pérot et al.,
2015).
For non-LTR retrotransposons, LINE-1 was found to be
overexpressed in tumor samples of pancreatic and prostate
cancers (Contreras-Galindo et al., 2008; Criscione et al., 2014).
De novo L1 insertions were found in colorectal cancer (Solyom
et al., 2012). L1-mediated retrotransposition was suggested a
potentially crucial source of mutations that can decrease the
tumor suppression of somatic cells in hepatocellular carcinoma
(Shukla et al., 2013). Few SINE subfamily were expressed
differently in prostate cancer (Criscione et al., 2014).
Interesting findings about repetitive elements especially on
epithelial cancers led to approval of patent for using some kinds
of REs as biomarker in detection, prognosis and follow-up of
several carcinomas. It raised the question about REs expression in
sarcoma, a different kinds of malignant diseases. These repeated
DNA sequences are not yet analyzed in case of osteosarcoma
and it would be necessary to analyse their impact on the disease.
Hence, we conducted this study with aim to reveal the differential
expression of repeated DNA elements in osteosarcoma.
MATERIALS AND METHODS
Patients
This study was carried out in accordance with the
recommendations of The Helsinki declaration. The protocols
and informed consent forms used in the study were approved by
the Ethics Review Committee on Biomedical Research of Hue
University of medicine and pharmacy. All the participants or
representative of patients signed the informed consents after
being explained about the study.
Eighteen Vietnamese patients who had histologically
confirmed osteosarcoma and who were indicated for surgery
(limb sparing or amputation) were involved. The normal bone
and cancerous bone were sampled from the removal part right
after the operation. All of these samples were transported with
dry ice and were stored at−80◦C until RNA extraction.
RNA Extraction from Bone Tissue
Forty to fifty milligrams of bone sample was grinded with
nitrogen by pestle and mortar into powder and pre-treated
with trizol. We used RNeasy Fibrous Tissue Mini Kit (Qiagen,
Valencia CA, USA) to extract total RNA from bone tissue
according to the manufacturer’s protocol. Extracted RNA was
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dissolved in RNase free water and stored at −80◦C. Agilent 2100
Bioanalyzer and the RNA 6000 Nano Kit (Agilent Technologies
Inc., CA, USA) were used to measure the quality of total RNA.
By applying Ovation RNA-Seq System V2 (NuGen,
Emeryville, CA, USA), Fifty nanograms of total RNA was
amplified. The collected cDNAswere pooled in equal amount and
we used the pool to prepare the DNA fragment library by using
SOLiD System chemistry (Life Technologies Corp, Carlsbad, CA,
USA). SOLiD 5500W platform and DNA sequencing chemistry
(Life Technologies Corp., Carlsbad, CA, USA) were applied for
sequencing. By using Maxmapper algorithm implemented in the
Lifescope software (Life Technologies, Ltd), Raw reads (75 bp)
were color-space mapped to the human genome hg19 reference
using. It was permitted to map multiple locations. The mapping
confidence was more than 90 because the quality threshold was
set to 10. Reads were filtered out if the score was <10. Mapping
quality was at an average of 30. The RepEnrich pipeline with
RepeatMasker hg19 library as reference was used for obtaining
read counts based on reads aligning to repeated element loci.
Statistical Analysis
For statistical analysis, edgeR (empirical analysis of DGE-digital
gene expression in R) package for R was used (Robinson
et al., 2010). EdgeR is a bioconductor package in R used to
analyse the differential expression of digital gene expression
data. It was developed for RNA-seq or other counts data. It
provides methods to analyse the differential expression by using
the negative binomial distribution and a shrinkage estimator
for the distribution’s variance. The Package performs sample
comparison and it can adjust the P-value to overcome problems
of multiple testing (Li et al., 2012; McCarthy et al., 2012;
Anders et al., 2013). EdgeR package uses Benjamini-Hochberg
procedure to control the false discovery rate (FDR) (Benjamini
and Hochberg, 1995).
RESULTS
General Characteristics of Osteosarcoma
Patients in the Study
We collected samples after surgical removal of affected bone from
18 Vietnamese osteosarcoma patients. Each surgically removed
sample contained paired tumor and normal part. Pathologist
confirmed the diagnosis after histological analysis. Among 18
patients, there were 06 (33.33%) females and 12 (66.67%) males.
The mean age was 18.11, which ranged from 7 to 52 years.
Affected sites were at femur 55.56%, tibia (33.33%) and humerus
(11.11%). The Table 1 shows an overview of the involved OS
patients.
Repetitive Elements/Repeated Sequence
(Repeats) Were Found Differently
Expressed between Osteosarcoma and
Normal Bone Tissue
We analyzed 1116 different repeated elements from the Repbase.
Benjamini-Hochberg (BH) adjustment which is implemented in
edgeR was used to eliminate the false positives. These values,
TABLE 1 | Characteristics of osteosarcoma patients in the present study.
Patient
code
Age at
diagnosis
Gender Site of
tumor
Metastasis
at diagnosis
Chemotherapy
OSVN001 16 Female Femur No Yes
OSVN003 13 Male Femur No Yes
OSVN004 16 Female Femur No Yes
OSVN005 18 Male Femur No Yes
OSVN006 18 Male Femur No Yes
OSHN008 24 Female Tibia No yes
OSVN008 52 Male Femur Yes No
OSHN009 16 Male Femur No Yes
OSHN010 20 Female Femur No Yes
OSHN011 07 Male Tibia No Yes
OSHN012 11 Male Humerus No No
OSHN013 17 Male Femur No No
OSHN014 16 Female Tibia No Yes
OSVN015 15 Male Tibia No Yes
OSHN015 8 Female Tibia No Yes
OSHN016 20 Male Femur No Yes
OSHN017 16 Male Humerus No Yes
OSDN001 23 Male Tibia Yes Yes
called the BH-adjusted p-values (FDR), were demonstrated in the
column FDR. Hence, if we consider that 10 percent is a acceptable
fraction for false positives, we can consider all repetitive elements
with an adjusted p-value <10% = 0.1 as significant ones. Here
we accepted the level of 5% false positives by using FDR <0.05.
Consequently, 82 repetitive elements were found differentially
expressed between the normal and osteosarcoma tissues. Of
which, 35 elements were upregulated and 47were downregulated.
Ranking by FDR, we have the list of elements with the
lowest FDR known as the most significant elements differentially
expressed in OS samples compared to normal ones. Ten elements
with the lowest FDR were shown in the Table 2. The highest
significant ones were THE1C-int, LTR5,MER57F,MER87Bwhich
are all belong to HERVs, a part of repetitive elements. We will
discuss more about these elements in the discussion part. We also
have two satellites HSATII and ALR_Alpha in the list.
Ranking by logFC, we got a list of the most upregulated
elements (Table 3) which have the highest logFC (1.12–2.05).
The most upregulated elements were SAR, HSATII, _CATTC_n,
MER136, ALR_Alpha, _GAATG_n. The most downregulated
elements were mostly HERVs (Table 4).
The Figure 1 shows clearly the upregulated and
downregulated repetitive elements in OS where we can see
the most upregulated and the most downregulated ones with the
range of logFC (Figures 1A,B). PCA shows nicely the difference
between OS and normal bone in repetitive elements expression
(Figure 1C). Figure 2 is a heatmap of differentially expressed
repetitive elements at FDR ≤ 0.05 in OS vs. normal bone tissue.
We can see clear pattern that differentiate between tumor and
normal samples. Z-scores of the top five differentially expressed
repetitive elements with lowest FDR values representes as
boxplots in the Figure 3.
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TABLE 2 | Ranking from the lowest FDR, ten most significant REs expressed
differentially between osteosarcoma and normal control, FDR < 0.001.
Class Family Element logFC p-value FDR
LTR ERVL-MaLR THE1C-int 0.612785 9.83E-10 1.07E-06
LTR ERVK LTR5 0.606272 4.58E-08 2.49E-05
LTR ERV1 MER57F 0.943969 1.09E-07 2.98E-05
LTR ERV1 MER87B 0.748537 1.01E-07 2.98E-05
RNA RNA 7SK 0.9486 3.17E-07 6.91E-05
LTR ERV1 MER34B-int 0.72914 4.78E-07 8.68E-05
LTR Gypsy MamGypLTR3 −0.41918 7.13E-07 0.000111
Satellite centr ALR_Alpha 1.291039 1.08E-06 0.000147
DNA DNA MER136 1.412429 1.27E-06 0.000154
Satellite Satellite HSATII 1.878344 3.66E-06 0.000366
REs with the lowest FDR were THE1C-int, LTR5, MER57F, MER87B. These elements
belong to long terminal repeats (LTR) class and they are all upregulated in OS (logFC
> 0.5). ALR_Alpha and HSATII were the most significant satellites that expressed
differentially between OS and normal control samples.
TABLE 3 | Satellites were found to be the most upregulated elements in OS.
Class Family Element logFC p-value FDR
Satellite Satellite SAR 2.052918 5.08E−05 0.003461
Satellite Satellite HSATII 1.878344 3.66E−06 0.000366
Satellite Satellite _CATTC_n 1.481369 3.7E−06 0.000366
DNA DNA MER136 1.412429 1.27E−06 0.000154
Satellite centr ALR_Alpha 1.291039 1.08E−06 0.000147
Satellite Satellite _GAATG_n 1.115843 0.000789 0.01829
By ranking logFC, the highest ones compose of SAR, HSATII, and -CATTC-n with high
significance (FDR < 0.01).
TABLE 4 | Ranking by the lowest logFC, the table includes the most
downregulated repetitive elements in osteosarcoma.
Class Family Element logFC p-value FDR
DNA TcMar MamRep1161 −0.99091 6.38E−05 0.003862
tRNA tRNA tRNA-Ser-TCY −0.94009 0.001438 0.026562
LTR ERV1 HERV1_LTRe −0.68333 0.000166 0.007247
LTR ERVL-MaLR MLT1E1-int −0.64431 0.00306 0.043679
LTR ERV1 HERV15-int −0.61309 0.000353 0.010703
LTR ERV1 MER51E −0.5277 0.000964 0.02144
LTR ERV1 MER83B −0.43948 0.000292 0.010112
LTR ERVL LTR47B4 −0.43666 7.71E−05 0.0042
LTR Gypsy MamGypLTR3 −0.41918 7.13E−07 0.000111
LTR ERV1 MER72B −0.37858 0.000402 0.011198
LTR Gypsy LTR81 −0.35087 0.003015 0.043679
LTR ERV1 LTR31 −0.34699 0.000763 0.01808
They are mostly HERVs.
DISCUSSION
To our present knowledge, no similar study was carried out
in osteosarcoma. We found herein 82 repetitive elements
which were expressed differentially with significance FDR
<0.05 between osteosarcoma and adjacent normal bone in
paired samples. Of which, 35 were upregulated and 47 were
downregulated with FDR <0.05.
The top most significant differentially expressed repetitive
elements (with lowest FDR) were THE1C-int, LTR5, MER57F,
and MER87B. Interestingly, they all belong to LTR elements
or HERVs with DNA transposons made up of transposable
elements (TEs). THE1C-int is a ERV3, a retrovirus-like MaLR
element, consisting of 375 bp. LTR5 is ERV2, clone of HERV-
K18 consisting of 969 bp. MER57F is a ERV1 with 435 bp
and MER87B is also a ERV1 of 509 bp (Jurka et al., 2005;
Bao et al., 2015). To our knowledge, THE1C-int, MER57F,
and MER87B were not yet mentioned to be correlated with
diseases in previous literature. While LTR5 hypomethylation
was found to be correlated to systemic lupus erythematosus
mechanism (Nakkuntod et al., 2013). Many studies and
observations suggested an important role of transposable
elements in genomic instability, transcriptional control, non-
coding RNA regulation, oncogenic activation and chromosomal
rearrangements, Anwar et al. (2017). HERVs was mentioned a lot
recently as a TE that may have a role in carcinogenesis in many
different cancers that we got some evidences based on present
literature.
In prostate cancer, HERV-E (and/or ERV3) env genes was
expressed only in prostate tumor cells that suggested as targets for
immunotherapy for the disease (Wang-Johanning et al., 2003).
HERV-K was also identified to be involved to prostate cancer. It
was found that forward and reverse transcripts of severalHERV-K
loci were detected in prostate cancer cell lines (Agoni et al., 2013)
and overexpression of HERV-K (22q11.23) was associated with
hypomethylation of the HERV-K locus in the disease (Goering
et al., 2011). Interestingly, in a study of 14 patients with different
grades of prostate cancer in paired samples (prostate tumor and
normal tissue), 475 retrotransposon subfamilies were detected to
be significantly differential expression in tumor tissue with FDR
< 0.05. Among thoses elements, LTR was the most prevalent and
most of them were endogenous retroviruses with ERV1 being the
most represented (Ren et al., 2012; Criscione et al., 2014).
In ovarian cancer, HERV-K env protein was expressed in
epithelial ovarian cancer with high frequency (90%) without
expression in normal and benign ovarian surface epithelial
tissue. Interestingly, ERV3 and HERV-E were found to expressed
simultaneously in the same ovarian cancer tissues and antibodies
to HERVs were present in the sera of ovarian cancer. Authors
suggested that HERVs should be further studied to provide a
new ovarian cancer screening tool and potentially serve as a
new target for detection, diagnosis and treatment for this cancer
(Wang-Johanning et al., 2007). Methylation levels of HERV-K
and HERV-E were decreased in advanced ovarian cancer. HERV-
K hypomethylation was found to be correlated to ovarian cancer
aggressiveness and poor response to treatment (Iramaneerat
et al., 2011).
In breast cancer, HERV-K env was suggested to be a tumor
marker as it was expressed only in breast cancer tissues and cell
lines analyzed but not detected in normal breast tissues (Wang-
Johanning et al., 2001). HERV-K Env proteins were expressed in
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FIGURE 1 | Differential expression of repetitive elements in OS was shown here. (A) Shows differentially expressed repetitive elements with significance while (B)
Shows only elements expressed differentially with |logFC| > 0.5. (C) Shows the difference between tumor and non-tumor samples about REs expression.
more than 85% cases of breast cancer patients which induced
both serologic and cell-mediated immune responses (Wang-
Johanning et al., 2008). High titers of of env RNA of HERV-K
(HML-2) was found in the plasma of patients with breast cancer
(Contreras-Galindo et al., 2008).
Transposable elements were also studied in hepato-
gastrointestinal cancers. The HERV-H sequence was found
to be overexpressed in up to 30–50% of different gastrointestinal
cancers such as colorectal, gastric and pancreas cancers
(Wentzensen et al., 2007). Additionally, the gag gene of a HERV-
H locus on the chromosome Xp22 was commonly expressed in
colon malignant tissues (Alves et al., 2008). LTRs were found to
be upregulated and LTR-007 was noted to be the most frequently
expressed LTR in hepatocellular carcinoma (Hashimoto et al.,
2015).
Additionally, RNA from human endogenous retrovirus K
(HERV-K) (HML-2) can be found at a very high titers in the
plasma of lymphomas patients and it decreased dramatically
with succesful treatment of lymphoma (Contreras-Galindo et al.,
2008). A very interesting study on tumorigenesis of Hodgkin’s
lymphoma provided evidence that endogenous LTR activation
can be oncogenic and hypomethylation of the THE1B LTR
(a MaLR family LTR retrotransposon, the same family THE1
with THE1C-int found in our study) caused the CSF1R (colony
stimulating factor 1 receptor gene) oncogene activation. It
was emphasized that CSF1R was strongly expressed in these
malignant cells (Lamprecht et al., 2010).
HERVs were also studied in melanoma. HERV-K mRNA and
proteins were found in melanoma tissues and cell lines (Muster
et al., 2003; Büscher et al., 2005) andHERV-K (HML-2) loci being
transcribed in melanoma tissues was identified (Schmitt et al.,
2013).
HERVs was found in some germinal cancers. Production of
HERV-K virus-like particle was identified in teratocarcinoma cell
lines (Boller et al., 1993; Löwer et al., 1993); HERV-K Gag and
Env proteins were expressed in germ cell tumors and interestingly
antibodies against these proteins were also detected (Sauter et al.,
1995, 1996). Hypomethylation of several HERV-W loci seems
to be important in the HERV-W activation in testicular cancer
(Gimenez et al., 2010).
Though many studies revealed the role of HERVs in
oncogenesis, further studies need to be carried out for
further understanding the direct role of these elements in
cancer innitialization. Our findings here maybe the first in
osteosarcoma and they match with the present understanding
about transposable elements in cancer generally.
Ranking by logFC, we can generate some of the most
upregulated repetitive elements with highest logFC (Table 3).
Among those, SAR, HSATII and -CATTC-n were the top 3 most
upregulated ones.
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FIGURE 2 | Heatmap of REs expression in 18 paired- fresh-bone samples stratified by tumor and non-tumor group, class of REs, gender, and chemotherapy vs.
non-chemotherapy treated.
FIGURE 3 | Boxplot of z-score comparing tumor vs. normal samples in some most significant REs expressed in OS (LTR5, MER34B-int, MER57F, MER87B, and
THE1C-int). They were all upregulated in affected bone vs. normal bone.
SAR is a human satellite I DNA consisting of 84 BP with
sequence: acagtatata atatatattt tgggtacttt gatattttat gtacagtata
taatatatat tttgggtact ttgatatttt atgt (Jurka et al., 2005; Bao et al.,
2015). It has not been mentioned in previous studies on cancer.
This finding may suggest for further looking for its role in
osteosarcoma and we can discuss the function of SAR in the
light of another satellite element HSTAII, that is pericentromeric
human satellite II element. HSTAII was the second most
upregulated element in osteosarcoma after SAR. HSTAII was
found to be upregulated in some kinds of epithelial carcinomas
such as pancreatic adenocarcinoma, lung cancer, renal cancer,
ovarian, prostate cancer, colon cancer (Ting et al., 2011; Bersani
et al., 2015). In another study analyzing 15 human pancreatic
adenocarcinoma samples, 21-fold increased expression of all
satellites transcripts compared with normal pancreas has been
described. The highest differential expression was found for
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pericentromeric satellite HSATII. It was increased 131-fold in
pancreatic cancer and undetectable in normal pancreas or very
low expression in other normal tissues (Ting et al., 2011).
Overexpression of HSATII was also found in other cancers such
as lung cancer, kidney, ovarian and prostate. More interestingly,
using RNA-ISH analysis of endoscopic ultrasound-guided fine-
needle aspirates (EUS-FNA) of pancreatic masses revealed that
HSATII-positive cells were detected in 10/10 cases confirmed
adenocarcinoma in which 2 cases were non diagnostic with FNA
(Ting et al., 2011). This is very promising for further study in
the future on osteosarcoma with the present findings in epithelial
carcinomas. HSATII copy gain in colon cancer was associated
with a significant reduction in overall survival compared with
no gain tumors (Bersani et al., 2015). Interesting experiment
with colon cancer cells line treated by inhibiting HSATII rdDNA
formation in 3D conditions and mouse tumor xenografts lead
to tumor shrinking with reduction of HSATII copy number gain
(Bersani et al., 2015).
Simple satellite repeat (CATTC)n was found to be
overexpressed in human colon cancer simultaneously with
HSATII and ALR/alpha. This finding completely supports our
results where we found similar simultaneous upregulation of the
REs (Bersani et al., 2015).
Taken together, our findings of changed expression of
repetitive elements in osteosarcoma match with previous results
in epithelial, germinal, and hematologic cancers. It suggests that
REs could have potential biomarkers in detection, diagnosis and
follow-up osteosarcoma. It needs further studies to verify this
preliminary results.
We admitted that we have some limitations to be improved.
Our samples were heterogenous but it was acceptable to make
comparision between malignant group and control group due
to paired samples. Moreover, in the Figure 2, we can see
that patients without chemotherapy seem not to have higher
similarity in their subgroup. But it is difficult to make a
conclusion because only 3 patients did not receive chemotherapy
in 18 patients totally. Anyway, it raised a question to be verified if
the repetitive elements expression is changed with chemotherapy.
CONCLUSION
Eighty two repetitive elements were found differentially
expressed between the normal and osteosarcoma tissues. Of
which, 35 elements were upregulated and 47were downregulated.
The most significant repetitive elements differentially expressed
between OS and normal adjacent normal bone were HERVs
(THE1C-int, LTR5, MER57F, and MER87B). SAR, HSATII, and
simple repeat (CATTC)n were the most upregulated in OS. The
result of this study complements the known findings about
HERVs and satellite DNA expression in epithelial, germinal and
hematologic cancers and it indicates an interesting point to be
further studied in OS.
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